Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 TrialPeter Bader, Christina Peters, Ulrike Pöetschger et al.|Journal of Clinical Oncology|2015Cited by 132
Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real‐time PCRGunter Kerst, Peter Bader, Hermann Kreyenberg et al.|British Journal of Haematology|2005Cited by 122
Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patientsAnne Kruchen, Ingo Müller, Tanja Stahl et al.|Bone Marrow Transplantation|2015Cited by 15